Outset Medical Gross Margin 2019-2025 | OM
Current and historical gross margin for Outset Medical (OM) over the last 10 years. The current gross profit margin for Outset Medical as of September 30, 2025 is %.
| Outset Medical Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.12B | $0.05B | 38.66% |
| 2025-06-30 | $0.12B | $0.04B | 36.97% |
| 2025-03-31 | $0.12B | $0.04B | 36.52% |
| 2024-12-31 | $0.11B | $0.04B | 34.51% |
| 2024-09-30 | $0.12B | $0.04B | 31.30% |
| 2024-06-30 | $0.12B | $0.03B | 28.45% |
| 2024-03-31 | $0.13B | $0.03B | 24.80% |
| 2023-12-31 | $0.13B | $0.03B | 22.31% |
| 2023-09-30 | $0.13B | $0.03B | 19.85% |
| 2023-06-30 | $0.13B | $0.02B | 17.83% |
| 2023-03-31 | $0.12B | $0.02B | 16.10% |
| 2022-12-31 | $0.12B | $0.02B | 14.66% |
| 2022-09-30 | $0.11B | $0.02B | 13.39% |
| 2022-06-30 | $0.11B | $0.01B | 12.73% |
| 2022-03-31 | $0.11B | $0.01B | 10.00% |
| 2021-12-31 | $0.10B | $0.01B | 6.86% |
| 2021-09-30 | $0.09B | $0.00B | 4.40% |
| 2021-06-30 | $0.08B | $0.00B | -5.06% |
| 2021-03-31 | $0.07B | $-0.01B | -15.15% |
| 2020-12-31 | $0.05B | $-0.01B | -28.00% |
| 2020-06-30 | $0.02B | $-0.01B | -63.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.090B | $0.114B |
| Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $33.427B | 38.66 |
| Tempus AI (TEM) | United States | $10.416B | 0.00 |
| Doximity (DOCS) | United States | $7.021B | 28.91 |
| Hims & Hers Health (HIMS) | United States | $6.019B | 48.96 |
| IRhythm Holdings (IRTC) | United States | $5.017B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Hinge Health (HNGE) | United States | $2.773B | 0.00 |
| 10x Genomics (TXG) | United States | $2.525B | 0.00 |
| Heartflow (HTFL) | United States | $2.451B | 0.00 |
| Omnicell (OMCL) | United States | $2.185B | 44.68 |
| Inspire Medical Systems (INSP) | United States | $2.134B | 35.31 |
| Azenta (AZTA) | United States | $1.726B | 70.81 |
| Enovis (ENOV) | United States | $1.268B | 6.66 |
| Clover Health Investments (CLOV) | United States | $1.137B | 0.00 |
| Schrodinger (SDGR) | United States | $1.038B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.965B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Phreesia (PHR) | United States | $0.796B | 0.00 |
| Talkspace (TALK) | United States | $0.683B | 137.33 |
| Standard BioTools (LAB) | United States | $0.542B | 0.00 |
| Claritev (CTEV) | United States | $0.459B | 0.00 |
| Evolent Health (EVH) | United States | $0.364B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.362B | 0.00 |
| Carlsmed (CARL) | United States | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 14.09 |
| Senseonics Holdings (SENS) | United States | $0.296B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.264B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.261B | 0.00 |
| CapsoVision (CV) | United States | $0.256B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.197B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| CareCloud (CCLD) | United States | $0.114B | 6.28 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| Pulmonx (LUNG) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.018B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Zhongchao (ZCMD) | China | $0.011B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |